Id | Content |
---|---|
F1 | The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. |
F2 | Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. |
F3 | Includes 8,568 shares previously held by a grantor retained annuity trust, of which Mr. Dockendorff is the sole trustee, pursuant to an exempt transfer by such trust. |